S-100B and Neuron-specific Enolase (NSE) in Spinal Trauma

Medical University of Vienna60 enrolled

Overview

The investigators are studying the clinical worth of the serum markers S-100B and NSE in patients with spinal cord injuries e.g. in patients with vertebral fractures. If there is a injury to the neuronal structures these two proteins could be secreted into the serum and add evidence to the severity of the injury.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Spinal Cord Injury

Eligibility

Sex: ALLMin age: 1 Year

Medical Language ↔ Plain English

Inclusion Criteria: * vertebral fracture * injuries to the vertebral spine Exclusion Criteria: * head trauma * polytrauma

Locations (1)

Medical University of Vienna

Vienna, Vienna, Austria

Outcomes

Primary Outcomes

Neurological Symptoms

Time frame: 2 weeks

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.